Mechanisms of bone anabolism regulated by statins. Issue 6 (14th September 2012)

• Record Type: Journal Article
• Authors: Ruan, Feng; Zheng, Qiang; Wang, Jinfu
• Is Part Of: Bioscience reports. Volume 32:Issue 6(2012)
• Page Start: 511
• Page End: 519
• Publication Date: 2012-09-14
• Subjects: apoptosis -- mesenchymal stem cell (MSC) -- osteoclastogenesis -- osteogenesis -- osteoporosis -- statins; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20110118
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract : Osteoporosis is a common disease in the elderly population. The progress of this disease results in the reduction of bone mass and can increase the incidence of fractures. Drugs presently used clinically can block the aggravation of this disease. However, these drugs cannot increase the bone mass and may result in certain side effects. Statins, also known as HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors, have been widely prescribed for CVD (cardiovascular disease) for decades. Nonetheless, several studies have demonstrated that statins exert bone anabolic effect and may be helpful for the treatment of osteoporosis. Several experiments have analysed the mechanisms of bone anabolism regulated by statins. In the present paper, we review the mechanisms of promoting osteogenesis, suppressing osteoblast apoptosis and inhibiting osteoclastogenesis.